Urinary tract infections and candida albicans

Central European Journal of Urology

Volumn 68, Issue 1, 2015, Pages 96-101

  Behzadi, Payam ^a   Behzadi, Elham ^a   Ranjbar, Reza ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Candida albicans; Candida glabrata; Candida tropicalis; Urinary tract infection

Indexed keywords

AMPHOTERICIN B; BORIC ACID; FLUCONAZOLE; ITRACONAZOLE; VIRULENCE FACTOR;

APOPTOSIS; ARTICLE; BALANITIS; BIOFILM; CANDIDA ALBICANS; CANDIDURIA; CATHETERIZATION; CYSTITIS; ENDOCYTOSIS; HIGH RISK PATIENT; HUMAN; MORBIDITY; PATHOGENESIS; PREVALENCE; PYELONEPHRITIS; THIGMOTROPISM; TROPISM; URINARY TRACT INFECTION; VAGINA CANDIDIASIS;

EID: 84930694916     PISSN: 20804806     EISSN: 20804873     Source Type: Journal    
DOI: 10.5173/ceju.2015.01.474     Document Type: Article

References (40)

1. Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Cheshmeh MA, Omran D. Urinary tract infections associated with Candida albicans. Maedica. 2010; 5: 277-279.
2. Behzadi P, Behzadi E. The Microbial Agents of Urinary Tract Infections at Central Laboratory of Dr. Shariati Hospital, Tehran, IRAN. Turkiye Klinikleri J Med Sci. 2008; 28: 445.
3. Bouza E, San Juan R, Munoz P, Voss A, Kluytmans J. A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI− 003 study). Clin Microbiol Infect. 2001; 7: 523-531.
4. Helbig S, Achkar JM, Jain N, Wang X, Gialanella P, Levi M, Fries BC. Diagnosis and inflammatory response of patients with candiduria. Mycoses. 2013; 56: 61-69.
5. Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infection: pathogenesis. Clin Infect Dis. 2011; suppl 6: S437-451.
6. Behzadi P, Behzadi E. Modern Medical Mycology and Opportunistic Pathogenic Yeasts. 1st ed. Tehran: Persian Science & Research Publisher; 2011.
7. Kotb AF, Ismail AM, Sharafeldeen M, Elsayed EY. Chronic prostatitis/chronic pelvic pain syndrome: the role of an antifungal regimen. Cent European J Urol. 2013; 66: 196-199.
8. Newman SL, Bhugra B, Holly A, Morris RE. Enhanced killing of Candida albicans by human macrophages adherent to type 1 collagen matrices via induction of phagolysosomal fusion. Infection and immunity. 2005; 73: 770-777.
9. Voltan AR, Fusco-Almeida AM, Mendes-Giannini MJS. Candiduria: Epidemiology, Resistance, Classical and Alternative Antifungals Drugs. SOJ Microbiol Infect Dis. 2014; 2: 1-7.
10. Behzadi P, Behzadi E, Ranjbar R. Pediatric oral thrush. Pediatru’ro. 2014; 34: 36-39.
11. Behzadi P, Behzadi E. Environmental Microbiology. 1st ed. Tehran: Niktab Publisher; 2007.
12. Almeida AAd, Mesquita CSS, Svidzinski TIE, Oliveira KMPd. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop. 2013; 46: 335-339.
13. Tomczak H, Szałek E, Grześkowiak E. The problems of urinary tract infections with Candida spp. aetiology in women. Postepy Hig Med Dosw (online). 2014; 68: 1036-1039.
14. Ferreira AV, Prado CC, Carvalho RR, Dias K, Dias AL. Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections. Mycopathologia. 2013; 175: 265-272.
15. Paluchowska P, Tokarczyk M, Bogusz B, Skiba I, Budak A. Molecular epidemiology of Candida albicans and Candida glabrata strains isolated from intensive care unit patients in Poland. Mem Inst Oswaldo Cruz. 2014; 109: 436-441.
16. Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013; 4: 119-128.
17. Brunke S, Hube B. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol. 2013;15: 701-708.
18. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010; 23: 253-273.
19. Behzadi P, Behzadi E. Modern Fungal Biology. 1st ed. Tehran: Persian Science & Research Publisher; 2011.
20. Mahmoudabadi AZ, Zarrin M, Kiasat N. Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole in Candida albicans. Jundishapur J Microbiol. 2014; 7: e17105.
21. Wu H, Downs D, Ghosh K, Ghosh AK, Staib P, Monod M, et al. Candida albicans secreted aspartic proteases 4-6 induce apoptosis of epithelial cells by a novel Trojan horse mechanism. FASEB J. 2013; 27: 2132-2144.
22. Badiee P, Alborzi A, Joukar M. Molecular assay to detect nosocomial fungal infections in intensive care units. Eur J Intern Med. 2011; 22: 611-615.
23. Badiee P. Evaluation of Human Body Fluids for the Diagnosis of Fungal Infections. Biomed Res Int. 2013; 2013: 698325.
24. Bukhary Z. Candiduria: a review of clinical significance and management. Saudi J Kidney Dis Transpl. 2008; 19: 350.
25. Kauffman CA. Diagnosis and Management of Fungal Urinary Tract Infection. Infect Dis Clin North Am. 2014; 28: 61-74.
26. Sobel JD, Fisher JF, Kauffman CA, Newman CA. Candida urinary tract infections - epidemiology. Clin Infect Dis. 2011; suppl 6: S433-436.
27. da Silva EH, Ruiz LdaS, Matsumoto FE, Auler ME, Giudice MC, Moreira D, et al. Candiduria in a public hospital of São Paulo (1999-2004): Characteristics of the yeast isolates. Rev Inst Med Trop Sao Paulo. 2007; 49: 349-353.
28. Mónaco LS, Bosio O, Bava AJ. Candiduria nosocomial: etiología y prevalencia de sus agentes causales en el Hospital Paroissien; Nosocomial candiduria: Etiology and prevalence of its causal agents in Paroissien Hospital. Acta bioquím clín latinoam. 2010; 44: 705-709.
29. Adjapong G, Hale M, Garrill A. An investigation of the distribution of Candida species in genitourinary candidiasis and pelvic inflammatory disease from three locations in Ghana. Afr. J. Microbiol. Res. 2014; 8: 470-475.
30. Ozhak-Baysan B, Ogunc D, Colak D, Ongut G, Donmez L, Vural T, Gunseren F. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria. Med Mycol. 2012; 50: 529-532.
31. Jozepanahi M, Mobaien AR, Karami A, Ahadi S. Frequency of Candiduria in patients Hospitalized in Intensive Care Units. JKMS. 2011; 18: 228-234.
32. Mahmoudabadi AZ, Zarrin M, Fard MB. Antifungal Susceptibility of Candida Species Isolated From Candiduria. Jundishapur J Microbiol. 2013; 6: 24-28.
33. Awari A. Species distribution and antifungal susceptibility profile of Candida isolated from urine samples. Int J App Basic Med Res. 2011; 18: 228-234.
34. Omar M, Fam N, El-Leithy T, El-Said M, El-Seidi E, El-Etreby T. Virulence Factors and Susceptibility Patterns of Candida Species Isolated From Patients with Obstructive Uropathy and Bladder Cancer. Egypt J Med Microbiol. 2008; 17: 317-326.
35. Wissing H, Ballus J, Bingold TM, Nocea G, Krobot KJ, Kaskel P, et al. Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study. Infect Drug Resist. 2013; 6: 15.
36. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012; 36: 288-305.
37. Won EJ, Shin JH, Lee W-K, Koo SH, Kim SY, Park Y-J, et al. Distribution of yeast and mold species isolated from clinical specimens at 12 hospitals in Korea during 2011. Ann Clin Microbiol. 2013; 16: 92-100.
38. CHENG M-y, XIA B. Analysis of the distribution and antibiotic resistance of Candida isolated from patients with urinary tract infection. Chinese Journal of Microecology. 2013; 7: 027.
39. Yismaw G, Asrat D, Woldeamanuel Y, Unakal C. Prevalence of candiduria in diabetic patients attending Gondar University Hospital, Gondar, Ethiopia. Iran J Kidney Dis. 2013; 7: 102-107.
40. Moreira D, Auler ME, da Silva Ruiz L, da Silva EH, Hahn RC, Paula CR. Species distribution and antifungal susceptibility of yeasts isolated from vaginal mucosa. Rev Patol Trop. 2014; 43: 48-56.